(Q37748557)

22 August 2017

1 reference

title

The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile (English)

1 reference

22 August 2017

1 reference

Robério Amorim de Almeida Pondé

series ordinal

1

1 reference

22 August 2017

language of work or name

1 reference

11 May 2010

1 reference

Medical Microbiology and Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

200

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

13-22

1 reference

Diagnosis of hepatitis B virus infection through serological and virological markers.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Diagnosis of hepatitis B infections and monitoring of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Immunology of hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus genetic diversity and its impact on diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Detecting hepatitis B surface antigen mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Performance of a new-generation chemiluminescent assay for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Epidemiology and Prevention of Hepatitis B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

The humoral immune response in acute and chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Immune tolerance split between hepatitis B virus precore and core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Serological pattern of hepatitis C virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Molecular, immunological and clinical properties of mutated hepatitis B viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

The core promoter of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

HBsAG positive reactivity in man not due to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Characterization of HBV2-like infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

False positive results for the AUSZYME monoclonal test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Atypical hepatitis B virus in Spain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus type 2 infection in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Amplification and sequence analysis of the precore and core region of the HBV genome from sera of Spanish patients with HBV2‐like infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

The serology of chronic hepatitis B infection revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Assessing the impact of HBV NAT on window period reduction and residual risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0160-3

Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.

21 January 2018

1 reference

12 December 2020

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

12 December 2020

Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra

1 reference

12 December 2020

Brief surface antigenemia in newborn infants vaccinated with hepatitis B vaccine

1 reference

12 December 2020

Hepatitis B surface antigenemia in blood donors following vaccination

1 reference

12 December 2020

[Hepatitis B virus surface antigen reactivity in the absence of antibodies to core antigen: an atypical serological pattern having diverse significance]

1 reference

12 December 2020

Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers

1 reference

12 December 2020

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

12 December 2020

Prolonged hepatitis B surface antigenemia after vaccination

1 reference

12 December 2020

Pathology of livers infected with "silent" hepatitis B virus mutant

1 reference

12 December 2020

Clinical course and consequences of hepatitis B infection

1 reference

12 December 2020

Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization

1 reference

12 December 2020

Occult hepatitis B virus infection

1 reference

12 December 2020

Possible case of HBV-2 infection

1 reference

12 December 2020

Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.

1 reference

12 December 2020

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

1 reference

12 December 2020

False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay

1 reference

12 December 2020

Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization

1 reference

12 December 2020

Current incidence and residual risk of hepatitis B infection among blood donors in the United States.

1 reference

12 December 2020

Transient surface antigenemia in newborn infants vaccinated with Engerix B: occurrence and duration

1 reference

12 December 2020

Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation

1 reference

12 December 2020

Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen.

1 reference

12 December 2020

Hepatitis B surface antigen (HBsAg) assays--are they good enough for their current uses?

1 reference

12 December 2020

Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive blood donors

1 reference

12 December 2020

Changing scene in hepatitis B serology interpretation

1 reference

12 December 2020

Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro

1 reference

12 December 2020

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

1 reference

12 December 2020

Infection with HBV-2?

1 reference

12 December 2020

Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen

1 reference

12 December 2020

The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence

1 reference

12 December 2020

Hepatitis B surface antigen: decreased need for confirmation of reactive results

1 reference

12 December 2020

False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines

1 reference

12 December 2020

The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.

1 reference

12 December 2020

Improved detection of hepatitis B virus surface antigen by a new rapid automated assay

1 reference

12 December 2020

10.1007/S00430-010-0160-3

Identifiers

DOI

1 reference

22 August 2017

1 reference